by in
Entry Author Date Location
Celladon Gets FDA’s “Breakthrough Therapy” Status for Gene Therapy 04/10/14 San Diego
Backed By a Billionaire, Berg Pharma Aims to Speed Drugmaking 04/02/14 Boston
Houston Medtech Firm Procyrion Aims to Help Heart Heal Itself 03/25/14 Texas
San Diego’s Celladon Sets Price Range for IPO Shares 11/05/13 San Diego
UW Spinout, Beat Bio, Gets $2.5M to Treat Heart Failure 04/16/13 Seattle
CardioKinetix Clears 2-Year Study with Implant for Heart Failure 05/18/12 San Francisco
CircuLite Attracts Big Support for Tiny Heart-Assist Device 01/05/12 New York
Ambrx Grabs $24M Upfront in New Diabetes, Heart Failure Research Deal With Bristol-Myers 09/22/11 San Diego
BG Medicine Chief Speaks on Rough IPO Climate, (Finally) Going Public 04/21/11 Boston
HeartWare Gets $143.8M in Debt Offering 12/15/10 Boston
BG Medicine Wins FDA OK, Primes Pump for Second Shot at IPO 11/24/10 Boston
Feds’ Sequenom Probe Breaks Into the Open, Life Technologies Moves Into Synthetic Biology, DexCom Agrees to Re-Label Its Medical Devices, & More San Diego Life Sciences News 06/03/10 San Diego
Ending the Suspense, Celladon’s Gene Therapy Helps Heart Failure Patients in Small Study 06/01/10 San Diego
NormOxys Pockets $17.5M for Drugs Against Heart Failure, Cancer 05/24/10 Boston
Cytori Heartened by Cell Therapy in Two Small Studies of Cardiac Patients 05/07/10 San Diego
Celladon’s Gene Therapy Passes Heart Failure Trial; Maintains Suspense on Details 04/28/10 San Diego
QuantumCor Sees Future of Heart Failure Treatment in No Device Left Behind 11/02/09 Seattle
Celladon CEO Upbeat on Gene Therapy for Heart 05/29/09 San Diego
Targeted Genetics, Mainstay of Gene Therapy, Faces Likely Shutdown 05/07/09 Seattle
Targeted Genetics Hands Off Manufacturing 03/02/09 Seattle
Pathway Medical Gets Traction, Ekos Raises $12.5M, ZymoGenetics Sales Boss Departs, & More Seattle-Area Life Sciences News 02/05/09 Seattle
Cardiac Dimensions Wins European Clearance to Sell Device for Heart Failure 01/29/09 Seattle
Seattle Genetics Raises Dough, Trubion Feels Fallout of Pfizer Deal, Novo Sets Up Shop, & More Seattle-Area Life Sciences News 01/29/09 Seattle
NitroMed Takes Buyout Offer from Deerfield, Dumps Archemix at the Altar 01/27/09 Boston
Cardiac Dimensions, Fixer of Leaky Hearts, Edges Toward European Market and Pivotal U.S. Test 01/26/09 Seattle
MicroRNA Leaps Ahead: Alnylam-Isis Venture, Regulus, Shows Its Drug Works in Animals With Heart Failure 11/30/08 San Diego
Abiomed To Sell 2.4 Million Shares of Common Stock 08/19/08 Boston
Page 1 of 1